Related Experiment Video
Updated: Jan 23, 2026

Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
Acute kidney injury in pediatric hematopoietic stem cell transplant recipients
Julie C Fitzgerald1, Duane Williams2, Benjamin L Laskin3
1Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Insights
Pediatric hematopoietic stem cell transplant recipients frequently develop acute kidney injury, impacting survival and leading to chronic kidney disease. This review covers definitions, risk factors, pathophysiology, and management strategies for this critical complication.
Area of Science:
- Pediatric Hematology-Oncology
- Nephrology
- Stem Cell Transplantation
Background:
- Acute kidney injury (AKI) affects 21-55% of pediatric hematopoietic stem cell transplant (HSCT) recipients within 3 months.
- AKI in this population is linked to reduced survival and increased risk of chronic kidney disease (CKD).
- Understanding AKI's incidence, risk factors, and pathophysiology is crucial for improving outcomes.
Purpose of the Study:
- To review current definitions of acute kidney injury in pediatric HSCT.
- To describe the epidemiology and risk factors associated with AKI in this vulnerable group.
- To explore current and emerging management strategies and propose future research directions.
Main Methods:
- Literature review of studies on acute kidney injury following pediatric hematopoietic stem cell transplant.
- Analysis of current definitions, epidemiological data, and risk factors.
- Synthesis of current hypotheses regarding pathophysiology and proposed management changes.
Main Results:
- Acute kidney injury is a significant and common complication post-pediatric HSCT.
- Established risk factors and pathophysiological mechanisms contribute to AKI development.
- Current management strategies are evolving, with a need for further research.
Conclusions:
- Acute kidney injury poses a substantial threat to pediatric HSCT survivors.
- A comprehensive understanding of AKI's multifaceted nature is essential for clinical practice.
- Further research is warranted to refine management and improve long-term outcomes.
Abstract:
Acute kidney injury is common after pediatric hematopoietic stem cell transplant with a reported incidence of 21-55% in the first 3 mo after transplant. Acute kidney injury is associated with decreased survival and the development of chronic kidney disease in this patient population. In this review, current definitions of acute kidney injury are discussed. The epidemiology and risk factors for acute kidney injury in this patient population are described, and current hypotheses on the pathophysiology are reviewed. Current and emerging ideas about changes to management strategies to mitigate acute kidney injury are presented, and areas for further research are proposed.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

